Issue 32, 2022

An antioxidant boehmite amino-nanozyme able to disaggregate Huntington's inclusion bodies

Abstract

A novel amino-nanozyme, based on boehmite nanoparticles (BNPs) functionalised with a tetra-azapyridinophane (L1), has been designed to undermine some of the key issues underlying Huntington disease. L1 forms Cu2+ complexes with a striking SOD activity, while when grafted to the BNPs displays mitoROS scavenging properties and ability to disaggregate mutant huntingtin deposits in cells.

Graphical abstract: An antioxidant boehmite amino-nanozyme able to disaggregate Huntington's inclusion bodies

Supplementary files

Article information

Article type
Communication
Submitted
01 Mar 2022
Accepted
28 Mar 2022
First published
30 Mar 2022

Chem. Commun., 2022,58, 5021-5024

An antioxidant boehmite amino-nanozyme able to disaggregate Huntington's inclusion bodies

Á. Martínez-Camarena, M. Merino, A. V. Sánchez-Sánchez, S. Blasco, J. M. Llinares, J. L. Mullor and E. García-España, Chem. Commun., 2022, 58, 5021 DOI: 10.1039/D2CC01257J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements